Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
30 March 2017
E-001016/17E-001020/17
Joint answer given by Mr Andriukaitis on behalf of the Commission
Written questions: E-001016/17 , E-001020/17

The Commission is fully aware of the recent resolution of the European Parliament on the Paediatric Medicines Regulation. When the resolution was discussed at the December 2016 plenary meeting of the European Parliament the Commission welcomed the debate, as it confirms the shared interest of both Institutions to secure the best outcomes for children.

The Commission is currently working on a second report to the European Parliament and Council on the Paediatric Regulation, which will be delivered in 2017. For this, a public consultation was conducted which has recently been closed in February 2017.

The Commission will provide the European Parliament with more detailed comments on the Resolution in due course and as per usual procedure.

Last updated: 4 April 2017Legal notice